See analyst estimates and all valuation multiples for Chemicals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $243B | 7.3x | 18.5x | |
| $101B | 4.3x | 22.0x | |
| $84.4B | 5.3x | 22.8x | |
| $79.5B | 6.6x | 15.8x | |
| $69.3B | 0.9x | 7.5x | |
| $54.4B | 26.1x | 1452.1x | |
| $50.0B | 3.3x | 17.1x | |
| $49.8B | 2.8x | 7.2x | |
| $45.1B | 1.2x | 8.7x | |
| $42.9B | 1.6x | 7.6x | |
| $37.4B | 1.4x | 8.2x | |
| $36.8B | 0.9x | 7.9x | |
| $35.9B | 2.9x | 11.1x | |
| $35.0B | 7.4x | 19.9x | |
| $32.4B | 1.0x | 8.9x | |
| $30.8B | 2.0x | 11.6x | |
| $28.9B | 2.6x | 13.5x | |
| $26.8B | 6.7x | 37.3x | |
| $25.8B | 2.1x | 12.9x | |
| $23.4B | 4.0x | 10.0x | |
| $21.3B | 2.3x | 10.3x | |
| $21.1B | 3.6x | 10.7x | |
| $19.0B | 0.5x | 2.3x | |
| $18.8B | 1.9x | 8.6x | |
| $18.2B | 4.3x | 16.0x | |
| $17.9B | 3.0x | 14.3x | |
| $17.9B | 6.9x | 23.7x | |
| $17.1B | 2.8x | 7.2x | |
| $16.9B | 1.3x | 9.6x | |
| $16.7B | 2.3x | 14.6x | |
| $16.6B | 3.2x | 11.4x | |
| $16.5B | 1.0x | 13.4x | |
| $13.8B | 1.5x | 7.8x | |
| $13.8B | 0.8x | 5.7x | |
| $13.6B | 1.1x | 7.1x | |
| $13.3B | 0.9x | 5.7x | |
| $13.0B | 2.9x | 8.7x | |
| $12.4B | 2.4x | 11.9x | |
| $10.9B | 4.9x | 11.4x | |
| $10.9B | 3.6x | 9.7x | |
| $10.4B | 1.5x | 6.0x | |
| $10.2B | 1.3x | 6.3x | |
| $9.7B | 0.5x | 5.6x | |
| $9.4B | 1.7x | 13.6x | |
| $9.2B | 2.2x | 10.3x | |
| $9.1B | 0.8x | 5.2x | |
| $8.1B | 0.6x | 3.1x | |
| $7.0B | 7.3x | 27.1x | |
| $6.4B | 1.5x | 10.0x | |
| $6.3B | 2.9x | 8.6x | |
| $5.8B | 1.0x | 4.8x | |
| $5.8B | 1.1x | 9.7x | |
| $5.5B | 2.8x | 11.0x | |
| $5.5B | 0.7x | 7.7x | |
| $5.4B | 6.7x | 23.1x | |
| $5.4B | 1.0x | 6.3x | |
| $5.3B | 0.6x | 6.8x | |
| $5.2B | 12.0x | 38.3x | |
| $4.6B | 0.7x | 5.3x | |
| $4.6B | 1.8x | 13.5x | |
| $4.5B | 0.4x | 12.9x | |
| $4.2B | n/a | n/a | |
| $3.9B | 1.1x | 5.8x | |
| $3.7B | 1.7x | 8.3x | |
| $3.7B | n/a | n/a | |
| $3.6B | 0.9x | 15.8x | |
| $3.4B | 12.6x | 54.6x | |
| $3.2B | 5.2x | 29.5x | |
| $3.0B | 0.9x | -125.1x | |
| $2.6B | 0.6x | 3.7x | |
| $2.5B | n/a | n/a | |
| $2.4B | 0.8x | 6.3x | |
| $2.2B | 2.9x | 11.1x | |
| $2.1B | 2.1x | 11.3x | |
| $2.1B | 0.7x | 6.1x | |
| $1.8B | 0.2x | 5.1x | |
| $1.8B | 7.0x | 21.4x | |
| $1.7B | 1.5x | 11.4x | |
| $1.6B | 2.5x | 12.7x | |
| $1.5B | 1.5x | 8.6x | |
| $1.5B | 2.1x | 8.8x | |
| $1.4B | n/a | n/a | |
| $1.4B | 2.6x | n/a | |
| $1.2B | 1.2x | 11.9x | |
| $1.1B | 0.6x | 27.3x | |
| $1.0B | 0.7x | 7.2x | |
| $758M | n/a | n/a | |
| $728M | n/a | n/a | |
| $632M | 0.2x | 36.8x | |
| $623M | 1.3x | 6.4x | |
| $615M | 0.5x | 3.7x | |
| $604M | 1.0x | 7.2x | |
| $554M | n/a | n/a | |
| $541M | 0.4x | 5.8x | |
| $535M | 1.4x | 10.2x | |
| $471M | 0.8x | 5.3x | |
| $463M | 8.9x | 29.4x | |
| $445M | 1.8x | 11.4x | |
| $444M | 5.4x | -13.5x | |
| $433M | 0.6x | 5.7x | |
| $404M | 0.7x | 5.3x | |
| $403M | 0.8x | 2.7x | |
| $357M | 1.5x | 8.6x | |
| $349M | 0.2x | 3.2x | |
| $314M | n/a | n/a | |
| $292M | n/a | n/a | |
| $289M | 7.3x | -7.0x | |
| $289M | 0.5x | 7.2x | |
| $267M | n/a | n/a | |
| $253M | n/a | n/a | |
| $222M | n/a | n/a | |
| $205M | n/a | n/a | |
| $199M | 11.4x | -6.7x | |
| $179M | 0.4x | 4.4x | |
| $170M | 147.3x | -536.9x | |
| $153M | 0.6x | 3.8x | |
| $138M | 1.2x | 6.3x | |
| $129M | n/a | n/a | |
| $124M | 5.9x | -6.1x | |
| $115M | 5.5x | 16.5x | |
| $109M | n/a | n/a | |
| $101M | n/a | n/a | |
| $91.4M | n/a | n/a | |
| $80.0M | 38.4x | -2.2x | |
| $78.2M | n/a | n/a | |
| $77.4M | 0.8x | 4.2x | |
| $74.9M | 0.6x | 8.7x | |
| $74.3M | 356.8x | -12.0x | |
| $64.5M | n/a | n/a | |
| $48.0M | 0.5x | 4.5x | |
| $45.5M | n/a | n/a | |
| $45.2M | 12.5x | -6.8x | |
| $44.1M | 0.5x | 10.7x | |
| $43.8M | 2.5x | 15.4x | |
| $43.1M | 0.8x | 17.7x | |
| $37.2M | 1.7x | 30.1x | |
| $36.1M | 0.5x | 41.7x | |
| $34.9M | n/a | n/a | |
| $28.5M | 2.1x | 35.9x | |
| $26.8M | n/a | n/a | |
| $24.3M | n/a | n/a | |
| $21.5M | 2.0x | -9.9x | |
| $21.0M | n/a | n/a | |
| $20.8M | n/a | n/a | |
| $18.3M | n/a | n/a | |
| $17.5M | n/a | n/a | |
| $16.9M | n/a | n/a | |
| $16.6M | n/a | n/a | |
| $16.2M | 1.6x | -5.2x | |
| $15.8M | n/a | n/a | |
| $12.0M | n/a | n/a | |
| $11.3M | 1.8x | 344.0x | |
| $11.1M | n/a | n/a | |
| $8.6M | n/a | n/a | |
| $8.2M | 54.4x | -2.3x | |
| $6.7M | 127.6x | -8.6x | |
| $6.2M | n/a | n/a | |
| $5.5M | n/a | n/a | |
| $5.3M | n/a | n/a | |
| $5.1M | n/a | n/a | |
| $4.7M | n/a | n/a | |
| $4.3M | n/a | n/a | |
| $3.5M | n/a | n/a | |
| $3.3M | n/a | n/a | |
| $2.8M | n/a | n/a | |
| $2.7M | 7.6x | -0.2x | |
| $2.7M | n/a | n/a | |
| $2.1M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.6M | n/a | n/a | |
| $1.1M | n/a | n/a | |
| $0.9M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals